Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 1

Status

Recruiting 30Active not recruiting 30Completed 11Terminated 8Withdrawn 6Unknown 6Not yet recruiting 4

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 3Other solid neoplasm 1Gastrointestinal 1

Conditions

Endometrial Neoplasms 2MMRd/MSI-H Stage II-III Endometrial Cancer 1Locally Advanced Rectal Cancer (LARC) 1

Interventions

Cisplatin 122Carboplatin 121Drug Therapy 118Bevacizumab 105Capecitabine 99Oxaliplatin 97Radiotherapy 95Paclitaxel 88Gemcitabine 88tislelizumab 87Cyclophosphamide 86Specimen Handling 80pembrolizumab 76toripalimab 67Magnetic Resonance Spectroscopy 65Fluorouracil 62sintilimab 59Injections 57Surgical Procedures, Operative 56Docetaxel 54anlotinib 51130-nm albumin-bound paclitaxel 48Immune Checkpoint Inhibitors 47fludarabine 46Standard of Care 45Pemetrexed 43Blood Specimen Collection 43Biopsy 43venetoclax 41lenvatinib 41

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Not yet recruiting × dostarlimab × Clear all
NCT07381777 2026-02-02

IMMUNOSTAR

Gruppo Oncologico Italiano di Ricerca Clinica

Phase 2 Not yet recruiting
270 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer (LARC)

NCT07115927 2025-08-19

RODEO

University College, London

Phase 2 Not yet recruiting
40 enrolled
Gynecologic

Endometrial Neoplasms

NCT06897527 2025-07-08

A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC)

GlaxoSmithKline

Phase 4 Not yet recruiting
100 enrolled
Gynecologic

Endometrial Neoplasms

NCT07013851 2025-06-10

NADIA

Grupo Español de Investigación en Cáncer de Ovario

Phase 2 Not yet recruiting
25 enrolled
GynecologicOther solid neoplasm

MMRd/MSI-H Stage II-III Endometrial Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡